Brainomix 360 Stroke: See More. Do More. Save More.
Brainomix 360 Stroke unlocks expert-level insights from universally available non-contrast CT scans, supporting better treatment and transfer decisions.
Born out of the University of Oxford, Brainomix has long been a pioneer of stroke AI, delivering cutting-edge AI solutions that enhance clinical decision-making. Now we've raised the bar. Again.
Net Water Uptake
This first-of-its-kind capability provides a standardized, percentage-based measure of ischemic volume to inform treatment decisions and help predict clinical outcomes.
Core Volume
Assess ischemic core volume from universally available NCCT scans, with results demonstrating equivalency to CT Perfusion and MRI-derived assessments.
Expanding Stroke AI: How Net Water Uptake May Refine Thrombectomy & Transfer Decisions
NeurologyLive interviewed Dr George Harston and Dr James Briggs to learn more about the next-generation Brainomix 360 Stroke platform, which features a first-of-its-kind, automated net water uptake (NWU) capability from routine CT imaging that may refine stroke severity assessment, thrombectomy selection, and system-level treatment equity.
“At the system level, NCCT-based biomarkers, such as net water uptake, can help reduce variation across a whole network of hospitals and ensure that more patients are identified for life-changing treatment. Because non-contrast CT scans are widely available in all hospitals, standardized quantitative outputs can support consistent triage and transfer decisions regardless of local imaging resources. In a hub-and-spoke model, that consistency can translate into more uniform access to advanced therapies and fewer decisions driven primarily by geography or local experience.”
New Webinar:
"Imaging the Core on NCCT: Unlocking Stroke Insights Across Networks"
RECORDING AVAILABLE
In this April 2025 webinar, Dr Mehdi Bouslama (Neuroendovascular Surgery & Vascular Neurology at Broward Health, Florida) and Dr Kambiz Nael (Professor of Neuroradiology at the University of California, San Francisco) discuss their experience with Brainomix Core Volume, with research results demonstrating equivalency to CT Perfusion and MRI-derived core volume assessments.
Elevating Stroke Care Across the US: The Brainomix Impact
CONTACT OUR TEAM
"Brainomix has the strategy to really make an impact in the US for stroke patients. It's our mission to get all patients access to expert-level care on a network-wide level," Brad Wittenberg.
"We are enabling access to stroke intervention, tripling the number of patients achieving functional recovery. We have validated results linked to treatment, not just time savings," Audrey Sheeley.
Learn More Here.
Collaborating and Innovating with our Partners
Winner
Reddot Award: Design Concept 2025
Winner
Top Science Award at AHA Health Tech Competition 2025
Winner
Best Established MedTech Company 2025
Winner
Life Sciences & Health Tech Company of the Year
Winner
HealthTech Company of the Year 2024
Winner
Most Transformative HealthTech Company 2024
Winner
Life Sciences & HealthTech Company of the Year 2023
Winner
Innovative Tech Company
Winner
Best Established MedTech Company 2023